Whisper it, but we may finally be seeing the IPO window reopening in 2026. | Whisper it, but we may finally be seeing the IPO window reopening in 2026.

Heavyweight European venture capital firms like Novo Holdings and Sofinnova Partners have joined together to make the case for more urgently needed funding in the continent's biotech ecosystem. | In ...

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping the landscape for the industries. Public ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

A scientist wearing blue gloves and using a pipette handles samples in a laboratory. Liquid sampling in the laboratory. The cash for new biotech start-ups is still hard to find. Credit: Lander ...

NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities ...

India is at a defining moment in its scientific and economic journey. With the establishment of Anusandhan National Research Foundation (ANRF), the country has made a bold commitment to nurturing ...

The State Street SPDR S&P Biotech ETF (XBI) was launched on January 31, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of ...

Increase in demand for generic medicines have also led to increase in shift toward use of biotech ingredients. In addition, rise in consumption in the food & beverages industry and various health ...